Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.495 CAD | +3.12% | +3.12% | +15.12% |
Mar. 27 | Satellos Bioscience Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 27 | Satellos Bioscience Announces FY 2023 Results | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Frank Gleeson
FOU | Founder | 68 | 17-12-31 |
Michael Rudnicki
FOU | Founder | - | 17-12-31 |
Director of Finance/CFO | - | 23-08-31 | |
Courtney Wells
COO | Chief Operating Officer | - | - |
J. Hall
ADM | Chief Administrative Officer | - | 19-12-31 |
Philip Lambert
CTO | Chief Tech/Sci/R&D Officer | 56 | 22-09-26 |
Ryan Mitchell
PRN | Corporate Officer/Principal | - | - |
Michael B. Cross
PRN | Corporate Officer/Principal | 59 | - |
Warren Whitehead
PRN | Corporate Officer/Principal | 71 | 21-08-12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | - |
Geoff MacKay
CHM | Chairman | 57 | 18-08-31 |
William McVicar
BRD | Director/Board Member | 66 | - |
Brian Bloom
BRD | Director/Board Member | 48 | 18-03-31 |
Michael Rudnicki
FOU | Founder | - | 17-12-31 |
Frank Gleeson
FOU | Founder | 68 | 17-12-31 |
Adam Mostafa
BRD | Director/Board Member | 44 | 21-12-04 |
William Jarosz
BRD | Director/Board Member | - | - |
Rima Al-awar
BRD | Director/Board Member | - | 21-12-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 112,791,658 | 98,752,661 ( 87.55 %) | 0 | 87.55 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.12% | 39.55M | |
-2.53% | 103B | |
+1.77% | 95.28B | |
+1.57% | 22.15B | |
-15.39% | 21.02B | |
-8.58% | 18.15B | |
-41.01% | 16.73B | |
-13.23% | 16.05B | |
+3.98% | 13.68B | |
+34.71% | 12.17B |
- Stock Market
- Equities
- MSCL Stock
- Company Satellos Bioscience Inc.